Brief: Bubs Australia Secures Permanent Us FDA Approval For Infant Formula
07/09/2026 02:35
BRIEF-Bubs Australia Secures Permanent Us FDA Approval For Infant Formula Sept 7 (Reuters) - Bubs Australia Ltd BUB.AX:
BUBS AUSTRALIA LTD - BUBS SECURES PERMANENT US FDA APPROVAL FOR INFANT FORMULA
Further company coverage: BUB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump